Sam Chun Dang Pharm. Co. Ltd (000250) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.044x

Based on the latest financial reports, Sam Chun Dang Pharm. Co. Ltd (000250) has a cash flow conversion efficiency ratio of -0.044x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-15.17 Billion ≈ $-10.28 Million USD) by net assets (₩343.90 Billion ≈ $233.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Sam Chun Dang Pharm. Co. Ltd to measure how much of total assets are equity-financed.

Sam Chun Dang Pharm. Co. Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Sam Chun Dang Pharm. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Sam Chun Dang Pharm. Co. Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Sam Chun Dang Pharm. Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sam Chun Dang Pharm. Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Dlocal Ltd NASDAQ:DLO	0.186x
Diamondrock Hospitality Company Common Stock NASDAQ:DRH	0.015x
Dongfang Electronics Co Ltd SHE:000682	0.033x
Boise Cascad Llc NYSE:BCC	-0.008x
Hamilton Insurance Group, Ltd. NYSE:HG	0.037x
DO & CO Aktiengesellschaft VI:DOC	0.150x
Ruentex Development Co Ltd TW:9945	0.017x
Macrolink Real Estate Co Ltd SHE:000620	0.010x

Annual Cash Flow Conversion Efficiency for Sam Chun Dang Pharm. Co. Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Sam Chun Dang Pharm. Co. Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Sam Chun Dang Pharm. Co. Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩266.11 Billion ≈ $180.34 Million	₩21.77 Billion ≈ $14.75 Million	0.082x	+4.22%
2023-12-31	₩298.46 Billion ≈ $202.26 Million	₩23.43 Billion ≈ $15.88 Million	0.078x	+2.70%
2022-12-31	₩173.74 Billion ≈ $117.74 Million	₩13.28 Billion ≈ $9.00 Million	0.076x	+272.65%
2021-12-31	₩174.09 Billion ≈ $117.98 Million	₩-7.71 Billion ≈ $-5.22 Million	-0.044x	-354.23%
2020-12-31	₩186.63 Billion ≈ $126.47 Million	₩3.25 Billion ≈ $2.20 Million	0.017x	-91.02%
2019-12-31	₩157.87 Billion ≈ $106.99 Million	₩30.60 Billion ≈ $20.74 Million	0.194x	+15.00%
2018-12-31	₩148.52 Billion ≈ $100.65 Million	₩25.03 Billion ≈ $16.97 Million	0.169x	-8.68%
2017-12-31	₩141.34 Billion ≈ $95.78 Million	₩26.09 Billion ≈ $17.68 Million	0.185x	+30.05%
2016-12-31	₩125.17 Billion ≈ $84.82 Million	₩17.76 Billion ≈ $12.04 Million	0.142x	-6.45%
2015-12-31	₩114.32 Billion ≈ $77.47 Million	₩17.34 Billion ≈ $11.75 Million	0.152x	+8.38%
2014-12-31	₩139.68 Billion ≈ $94.66 Million	₩19.55 Billion ≈ $13.25 Million	0.140x	+4.69%
2013-12-31	₩119.23 Billion ≈ $80.80 Million	₩15.94 Billion ≈ $10.80 Million	0.134x	+622.90%
2012-12-31	₩86.63 Billion ≈ $58.71 Million	₩1.60 Billion ≈ $1.09 Million	0.018x	--

About Sam Chun Dang Pharm. Co. Ltd

KQ:000250 Korea Pharmaceuticals

Market Cap

$2.39 Billion

₩3.53 Trillion KRW

Market Cap Rank

#5605 Global

#125 in Korea

Share Price

₩164700.00

Change (1 day)

-0.24%

52-Week Range

₩126500.00 - ₩1000000.00

All Time High

₩1000000.00